Down-regulation of transcription elogation factor A (SII) like 4 (TCEAL4) in anaplastic thyroid cancer (Q21260418)

20 August 2022

Masamitsu Onda

2

Masamitsu

Onda

1 reference

20 August 2022

Junichi Okamoto

3

Junichi

Okamoto

1 reference

20 August 2022

Shizuyo Miyamoto

4

Shizuyo

Miyamoto

1 reference

20 August 2022

Mitsuji Nagahama

5

Mitsuji

Nagahama

1 reference

20 August 2022

Kouichi Ito

6

Kouichi

Ito

1 reference

20 August 2022

Akira Yoshida

7

Akira

Yoshida

1 reference

20 August 2022

Kazuo Shimizu

8

Kazuo

Shimizu

1 reference

Down-regulation of Rous sarcoma virus long terminal repeat promoter activity by a HeLa cell basic protein

20 August 2022

language of work or name

English

0 references

publication date

2006

0 references

published in

BMC Cancer

0 references

volume

6

0 references

issue

1

0 references

page(s)

260

0 references

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1635733

Genomic structure and chromosomal localization of TCEAL1, a human gene encoding the nuclear phosphoprotein p21/SIIR

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1635733

A HeLa-cell-encoded p21 is homologous to transcription elongation factor SII

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1635733

BRAF mutations in thyroid tumors are restricted to papillary carcinomas and anaplastic or poorly differentiated carcinomas arising from papillary carcinomas

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1635733

Anaplastic transformation of thyroid cancer: review of clinical, pathologic, and molecular evidence provides new insights into disease biology and future therapy

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1635733

Insular and anaplastic carcinoma of the thyroid: a 45-year comparative study at a single institution and a review of the significance of p53 and p21.

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1635733

Bcl-2 protein expression in carcinomas originating from the follicular epithelium of the thyroid gland

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1635733

Decreased expression of haemoglobin beta (HBB) gene in anaplastic thyroid cancer and recovery of its expression inhibits cell growth

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1635733

Comprehensive gene expression profiling of anaplastic thyroid cancers with cDNA microarray of 25 344 genes.

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1635733

Antitumor effects of peroxisome proliferator activate receptor gamma ligands on anaplastic thyroid carcinoma.

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1635733

p53 re-expression inhibits proliferation and restores differentiation of human thyroid anaplastic carcinoma cells.

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1635733

Anaplastic carcinoma of the thyroid: A clinicopathologic study of 121 cases

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1635733

p53 gene mutations associated with anaplastic transformation of human thyroid carcinomas

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1635733

Molecular evidence of anaplastic transformation in coexisting well-differentiated and anaplastic carcinomas of the thyroid

19 June 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-6-260

Anaplastic spindle-cell squamous carcinoma arising in association with tall-cell papillary cancer of the thyroid: A potential pitfall.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-6-260

Y-box binding protein expression in thyroid neoplasms: its linkage with anaplastic transformation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-6-260

Maspin expression is directly associated with biological aggressiveness of thyroid carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-6-260

Anaplastic thyroid carcinoma: risk factors and outcome

21 January 2018

1 reference

12 December 2020

Anaplastic transformation of papillary thyroid carcinoma in recurrent disease in regional lymph nodes: a histologic and immunohistochemical study

1 reference

12 December 2020

Frequent mutation and nuclear localization of beta-catenin in anaplastic thyroid carcinoma

1 reference

12 December 2020

Anaplastic (undifferentiated) thyroid carcinoma (ATC). A retrospective analysis

1 reference

12 December 2020

Allelotyping of anaplastic thyroid carcinoma: frequent allelic losses on 1q, 9p, 11, 17, 19p, and 22q

1 reference

12 December 2020

The role of cell cycle regulatory protein, cyclin D1, in the progression of thyroid cancer

1 reference

12 December 2020

Identifiers

DOI

10.1186/1471-2407-6-260

0 references